Episodes 121-135 of 762
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiersUnraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiersStudying Cortical Lesions in MS: Future Research Directions
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiersmIDH Gliomas Explained: Characteristics and Management Strategies
Climate Change in the Clinic: Examining Neurological Impacts
NeuroFrontiersClimate Change in the Clinic: Examining Neurological Impacts
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiersFrom Diagnosis to Treatment: Challenges in Glioblastoma Care
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiersVorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
- advertisement
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
On the Frontlines of CIDPDecoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Genetics in Schizophrenia Management: Emerging Technological Strategies
On the Frontlines of SchizophreniaGenetics in Schizophrenia Management: Emerging Technological Strategies
Understanding CIDP: A Roadmap to Diagnosis
On the Frontlines of CIDPUnderstanding CIDP: A Roadmap to Diagnosis
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
On the Frontlines of CIDPEvolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiersInvestigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiersNext Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
- advertisement
Monitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
NeuroFrontiersMonitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
NeuroFrontiersEngineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
Advances in MS Management: Current and Future Directions
NeuroFrontiersAdvances in MS Management: Current and Future Directions
